Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Shaun Walsh"'
Autor:
Jaclyn M. Beca, Shaun Walsh, Kaiwan Raza, Stacey Hubay, Andrew Robinson, Elena Mow, James Keech, Kelvin K. W. Chan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Introduction While no direct comparative data exist for crizotinib in ROS1+ non-small cell lung cancer (NSCLC), studies have suggested clinical benefit with this targeted agent. The objective of this study was to assess the cost-effectivenes
Externí odkaz:
https://doaj.org/article/c1bbb30ac34c42b8a02c2b3fde4cc77c
Publikováno v:
Clinical Case Reports, Vol 7, Iss 4, Pp 644-647 (2019)
Key Clinical Message Nivolumab is associated with a number of immune‐regulated adverse events, including immune‐mediated colitis and may present following the discontinuation of treatment. Current guidance suggests lower doses of methylprednisolo
Externí odkaz:
https://doaj.org/article/c9b7061c7b3044d7a1e5d16c547949b6
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-11 (2018)
Abstract Background Patients with hemophilia and inhibitors generally face greater disease burden compared to patients without inhibitors. While raising awareness of relative burden may improve the standard of care for patients with inhibitors, compa
Externí odkaz:
https://doaj.org/article/d6f7fe0d0c37422a8240bd9059fea102
The impact of severe haemophilia and the presence of target joints on health-related quality-of-life
Autor:
Jamie O’Hara, Shaun Walsh, Charlotte Camp, Giuseppe Mazza, Liz Carroll, Christina Hoxer, Lars Wilkinson
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background Joint damage remains a major complication associated with haemophilia and is widely accepted as one of the most debilitating symptoms for persons with severe haemophilia. The aim of this study is to describe how complications of h
Externí odkaz:
https://doaj.org/article/1effbe44dc7744dca5c20a5dbb7279d6
Autor:
Jamie O’Hara, Shaun Walsh, Charlotte Camp, Giuseppe Mazza, Liz Carroll, Christina Hoxer, Lars Wilkinson
Publikováno v:
Health Economics Review, Vol 8, Iss 1, Pp 1-7 (2018)
Abstract Objectives Target joints are a common complication of severe haemophilia. While factor replacement therapy constitutes the majority of costs in haemophilia, the relationship between target joints and non drug-related direct costs (NDDCs) has
Externí odkaz:
https://doaj.org/article/fbb6f774065241ed9b7a5a5a118a97dc
Autor:
Investigators, Mark A. Baxter, Lindsay C. Spender, Shaun Walsh, Susan Bray, Gemma Skinner, Sharon King, Peter S. Hall, Matthew J. Seymour, Russell D. Petty, on behalf of the GO2 Investigators on behalf of the GO2
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2591
Gastroesophageal adenocarcinoma is a disease of older adults that is associated with a very poor prognosis. It is less common and has better outcomes in females. The reason for this is unknown but may relate to signalling via the main oestrogen recep
Autor:
Shankar, Kumar, Thomas, Parry, Sue, Mallett, Gauraang, Bhatnagar, Andrew, Plumb, Shaun, Walsh, Nigel, Scott, Ruchi, Tandon, Heung, Chong, John, du Parcq, Adrianna, Martinez, Morgan, Moorghen, Manuel, Rodriguez-Justo, Steve, Halligan, Stuart A, Taylor, Steve, Morris
Publikováno v:
Journal of Crohn's and Colitis. 16:1531-1539
Background and Aims The simplified magnetic resonance enterography [MRE] index of activity [sMARIA], London, and ‘extended’ London, scoring systems are widely used in Crohn’s disease [CD] to assess disease activity, although validation studies
Autor:
Stacey Hubay, James Keech, Kelvin K. W. Chan, Elena Mow, Jaclyn Beca, Andrew G. Robinson, Kaiwan Raza, Shaun Walsh
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Introduction While no direct comparative data exist for crizotinib in ROS1+ non-small cell lung cancer (NSCLC), studies have suggested clinical benefit with this targeted agent. The objective of this study was to assess the cost-effectiveness of criz
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-11 (2018)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Patients with hemophilia and inhibitors generally face greater disease burden compared to patients without inhibitors. While raising awareness of relative burden may improve the standard of care for patients with inhibitors, comparative da
Autor:
Madusha Meemanage, Lindsay C Spender, Diane Collinson, Joanna Iannetta, Pranavi Challapalli, Julie Turbitt, Caroline Clark, Mark Baxter, Graeme Murray, Shaun Walsh, Zofia Miedzybrodzka, Russell Petty
BACKGROUND Oesophageal squamous cell carcinoma (ESCC) has high mortality and poor prognosis. Advanced tumours are treated with fluoropyrimidine/platinum chemotherapy (PBC) followed by second-line irinotecan or taxane monotherapy, but resistance is co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ee2036b9ea6954abd5b99564871e403
https://doi.org/10.21203/rs.3.rs-31064/v1
https://doi.org/10.21203/rs.3.rs-31064/v1